We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Increases Despite Market Slip: Here's What You Need to Know
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) closed at $30.79 in the latest trading session, marking a +1.02% move from the prior day. The stock outpaced the S&P 500's daily loss of 0.31%. Elsewhere, the Dow saw a downswing of 0.25%, while the tech-heavy Nasdaq depreciated by 1.38%.
The stock of company has fallen by 1.17% in the past month, lagging the Finance sector's gain of 0.34% and the S&P 500's gain of 0.87%.
The upcoming earnings release of Oscar Health, Inc. will be of great interest to investors. The company's earnings report is expected on November 5, 2026. The company's upcoming EPS is projected at -$0.11, signifying a 79.25% increase compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $4.72 billion, showing a 58.14% escalation compared to the year-ago quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $1.83 per share and revenue of $18.81 billion, which would represent changes of +208.28% and +60.77%, respectively, from the prior year.
Investors should also take note of any recent adjustments to analyst estimates for Oscar Health, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Right now, Oscar Health, Inc. possesses a Zacks Rank of #1 (Strong Buy).
In terms of valuation, Oscar Health, Inc. is presently being traded at a Forward P/E ratio of 16.63. This denotes a premium relative to the industry average Forward P/E of 10.11.
Investors should also note that OSCR has a PEG ratio of 0.33 right now. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. OSCR's industry had an average PEG ratio of 1 as of yesterday's close.
The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 164, placing it within the bottom 34% of over 250 industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Oscar Health, Inc. (OSCR) Increases Despite Market Slip: Here's What You Need to Know
Oscar Health, Inc. (OSCR - Free Report) closed at $30.79 in the latest trading session, marking a +1.02% move from the prior day. The stock outpaced the S&P 500's daily loss of 0.31%. Elsewhere, the Dow saw a downswing of 0.25%, while the tech-heavy Nasdaq depreciated by 1.38%.
The stock of company has fallen by 1.17% in the past month, lagging the Finance sector's gain of 0.34% and the S&P 500's gain of 0.87%.
The upcoming earnings release of Oscar Health, Inc. will be of great interest to investors. The company's earnings report is expected on November 5, 2026. The company's upcoming EPS is projected at -$0.11, signifying a 79.25% increase compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $4.72 billion, showing a 58.14% escalation compared to the year-ago quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $1.83 per share and revenue of $18.81 billion, which would represent changes of +208.28% and +60.77%, respectively, from the prior year.
Investors should also take note of any recent adjustments to analyst estimates for Oscar Health, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Right now, Oscar Health, Inc. possesses a Zacks Rank of #1 (Strong Buy).
In terms of valuation, Oscar Health, Inc. is presently being traded at a Forward P/E ratio of 16.63. This denotes a premium relative to the industry average Forward P/E of 10.11.
Investors should also note that OSCR has a PEG ratio of 0.33 right now. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. OSCR's industry had an average PEG ratio of 1 as of yesterday's close.
The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 164, placing it within the bottom 34% of over 250 industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.